Dermatology
| Atopic Dermatitis
Dermatology
Atopic Dermatitis
Targeting IL-31 for atopic dermatitis and pruritic diseases
book_2
Source:
EADV 2024 - Oral session
calendar_today
Published on Medfyle:
October 2024
import_contacts
3
min
In this medfyle
Atopic dermatitis inflicts a chronic itch-scratch cycle, and this is one of the most bothersome symptoms, but targeting IL-31 appears to give symptom relief. Data presented at EADV 2024 showcase ATTO-1310 – a new biparatopic biologic.
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
©2024 Infomedica-Medfyle. All rights reserved.
Source: ATTO-1310: A first-in-class anti-IL31 Attobody® for atopic dermatitis and other pruritic diseases. Bellovin D, et al. Presented at EADV 2024; FC07.06; Abstract #4950.
The information and data provided is for information purposes only. The author(s) of the original original presentation had no involvement in the creation of this content.
